132 related articles for article (PubMed ID: 33847629)
1. Performance evaluation of CA242 by flow fluorescence assay.
Hou Y; Chen Y; Sun J; Geng J; Jin H; Zhang Z
Medicine (Baltimore); 2021 Apr; 100(15):e25301. PubMed ID: 33847629
[TBL] [Abstract][Full Text] [Related]
2. Performance Evaluation of Newly-Developed Tumor Markers Assay Kit Based on Flow Fluorescence Assay.
Jiang Y; Li Z; Li Z; Shi X; Chang L; Yan C
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623659
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a newly developed quantitative determination kit for tumor marker CA15-3 with chemiluminescent assay.
Li P; Ye H; Liu J; Jin H; Lin Y; Yan S; Yu Y; Gao L; Xu F; Zhang Z
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28233344
[TBL] [Abstract][Full Text] [Related]
4. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
5. Biotin Interference in Susceptible CanAg Ca242 Immunoassays and Elimination Method.
Huang H; Lin H; Huang L; Li Y; Li G; Huang J; Luo Y; Ke P
Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658421
[TBL] [Abstract][Full Text] [Related]
6. CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer.
Banfi G; Bravi S; Ardemagni A; Zerbi A
Int J Biol Markers; 1996; 11(2):77-81. PubMed ID: 8776607
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
9. Sensitive amplified luminescent proximity homogeneous assay for the quantitative detection of CA242.
Chen J; Fu B; Xiang Z; Chen X; Wang L; Qin Y; Zhao X; Zhou X; Liu P; Huang B
J Immunol Methods; 2023 Jun; 517():113487. PubMed ID: 37156407
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder.
Shukla VK; Gurubachan ; Sharma D; Dixit VK; Usha
Trop Gastroenterol; 2006; 27(4):160-5. PubMed ID: 17542293
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Tao LY; Cai L; He XD; Liu W; Qu Q
Am Surg; 2010 Nov; 76(11):1210-3. PubMed ID: 21140686
[TBL] [Abstract][Full Text] [Related]
12. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
[TBL] [Abstract][Full Text] [Related]
13. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
14. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
[TBL] [Abstract][Full Text] [Related]
15. Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer.
Dong D; Jia L; Zhang L; Ma N; Zhang A; Zhou Y; Ren L
Cancer Sci; 2018 Sep; 109(9):2841-2851. PubMed ID: 29945294
[TBL] [Abstract][Full Text] [Related]
16. Performance verification of five commercial RT-qPCR diagnostic kits for SARS-CoV-2.
Yang M; Cao S; Liu Y; Zhang Z; Zheng R; Li Y; Zhou J; Zong C; Cao D; Qin X
Clin Chim Acta; 2022 Jan; 525():46-53. PubMed ID: 34902345
[TBL] [Abstract][Full Text] [Related]
17. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a newly developed chemiluminescence immunoassay for detecting cardiac troponin T.
Wang J; Fang Y; Li P; Lin H; Jin H; Gao L; Ge S; Zhang ZY
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28940712
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.
Yang XQ; Chen C; Peng CW; Liu SP; Li Y
Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a membrane-bound and a secreted mucin-type glycoprotein carrying the carcinoma-associated sialyl-Lea epitope on distinct core proteins.
Baeckström D; Hansson GC; Nilsson O; Johansson C; Gendler SJ; Lindholm L
J Biol Chem; 1991 Nov; 266(32):21537-47. PubMed ID: 1718981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
